Frontlight ResearchEarly access
Trial site
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- 4running trials
- 4closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- High blood pressure2 trials
- Coronary artery disease1 trial
- Deep vein thrombosis and pulmonary embolism1 trial
- Heart failure1 trial
- Metastatic breast cancer1 trial
- Myeloproliferative neoplasms1 trial
- Pulmonary arterial hypertension1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 34 trials
- Phase 21 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed3 trials
- Recruiting3 trials
- Active, not recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Boehringer Ingelheim2 trials
- Endovascular Engineering1 trial
- Kartos Therapeutics, Inc.1 trial
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center1 trial
- Respira Therapeutics, Inc.1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Withdrawn
Completed
Completed
Completed
Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study
Site data: ClinicalTrials.govUpdated 17 Nov 2026